Form 4: Treace Medical Concepts SVP, Sales, Aaron Berutti, Reports Stock Disposal

Aaron Berutti, SVP of Sales at Treace Medical Concepts, disposed of 4,821 shares of common stock to cover tax obligations related to restricted stock units.

Summary

• Aaron Berutti, the Senior Vice President of Sales at Treace Medical Concepts, Inc., filed a Form 4 indicating a transaction involving the company's common stock.
• On January 10, 2025, Mr. Berutti disposed of 4,821 shares of common stock.
• This disposal was categorized as a transaction to cover tax obligations related to restricted stock units.
• Following the transaction, Mr. Berutti directly owns 160,970 shares of Treace Medical Concepts common stock, which includes 145,454 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing a stock disposal for tax purposes, which is neither positive nor negative for the company's outlook.

Industry Context

This is a routine SEC Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• Similar filings are made by executives at companies like Stryker (SYK) and Zimmer Biomet (ZBH) when they trade their company's stock.
• The number of shares disposed of is relatively small compared to the total holdings, which is typical for tax-related disposals of restricted stock units.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine disposal of shares by an executive for tax purposes.

Key Dates

Keywords

Treace Medical Concepts, TMCI, Aaron Berutti, Form 4, Stock Disposal, Restricted Stock Units, Insider Trading, SEC Filing